&Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.82M | Buy |
20,111
+487
| +2% | +$83.7K | 0.02% | 703 |
|
|
2026
Q1 | $3.31M | Buy |
19,624
+413
| +2% | +$70.6K | 0.02% | 688 |
|
|
2025
Q4 | $3.24M | Buy |
19,211
+3,462
| +22% | +$562K | 0.02% | 651 |
|
|
2025
Q3 | $2.27M | Buy |
15,749
+540
| +4% | +$73.7K | 0.01% | 701 |
|
|
2025
Q2 | $1.92M | Buy |
15,209
+195
| +1% | +$23.9K | 0.01% | 687 |
|
|
2025
Q1 | $1.96M | Buy |
15,014
+1,237
| +9% | +$168K | 0.02% | 545 |
|
|
2024
Q4 | $1.84M | Buy |
13,777
+4,635
| +51% | +$652K | 0.02% | 528 |
|
|
2024
Q3 | $1.33M | Sell |
9,142
-1,438
| -14% | -$208K | 0.03% | 461 |
|
|
2024
Q2 | $1.45M | Buy |
10,580
+4,197
| +66% | +$560K | 0.06% | 259 |
|
|
2024
Q1 | $876K | Buy |
6,383
+720
| +13% | +$98.3K | 0.12% | 169 |
|
|
2023
Q4 | $769K | Sell |
5,663
-153
| -3% | -$18.7K | 0.19% | 124 |
|
|
2023
Q3 | $711K | Sell |
5,816
-1,005
| -15% | -$128K | 0.33% | 60 |
|
|
2023
Q2 | $866K | Buy |
6,821
+30
| +0.4% | +$3.9K | 0.39% | 53 |
|
|
2023
Q1 | $877K | Sell |
6,791
-70
| -1% | -$9.16K | 0.42% | 49 |
|
|
2022
Q4 | $901K | Sell |
6,861
-117
| -2% | -$15.1K | 0.45% | 49 |
|
|
2022
Q3 | $816K | Sell |
6,978
-70
| -1% | -$8.69K | 0.47% | 50 |
|
|
2022
Q2 | $829K | Hold |
7,048
| – | – | 0.48% | 46 |
|
|
2022
Q1 | $918K | Hold |
7,048
| – | – | 0.52% | 44 |
|
|
2021
Q4 | $1.08M | Hold |
7,048
| – | – | 0.65% | 34 |
|
|
2021
Q3 | $1.14M | Hold |
7,048
| – | – | 0.72% | 33 |
|
|
2021
Q2 | $1.15M | Hold |
7,048
| – | – | 0.75% | 34 |
|
|
2021
Q1 | $1.06M | Buy |
7,048
+29
| +0.4% | +$4.61K | 0.77% | 34 |
|
|
2020
Q4 | $1.06M | Buy |
7,019
+176
| +3% | +$25.2K | 0.89% | 32 |
|
|
2020
Q3 | $927K | Sell |
6,843
-545
| -7% | -$73.9K | 0.94% | 32 |
|
|
2020
Q2 | $1.01M | Sell |
7,388
-268
| -4% | -$34.2K | 1.22% | 17 |
|
|
2020
Q1 | $825K | Sell |
7,656
-381
| -5% | -$43.9K | 1.28% | 16 |
|
|
2019
Q4 | $969K | Hold |
8,037
| – | – | 1.15% | 21 |
|
|
2019
Q3 | $800K | Sell |
8,037
-843
| -9% | -$88.2K | 1.04% | 21 |
|
|
2019
Q2 | $969K | Sell |
8,880
-320
| -3% | -$34K | 1.34% | 14 |
|
|
2019
Q1 | $1.03M | Sell |
9,200
-827
| -8% | -$90.7K | 1.47% | 12 |
|
|
2018
Q4 | $967K | Buy |
+10,027
| New | +$1.06M | 1.62% | 11 |
|
Other funds holding IBB
&Partners's IBB Position: Q2 2026 in Review
&Partners increased its iShares Biotechnology ETF (IBB) stake by 2.5% in Q2 2026, buying an estimated $83.7K and bringing the position to 20,111 shares worth $3.82M. The position accounts for 0.02% of the portfolio, ranked #703.
&Partners first reported a position in IBB in Q4 2018 and has held it in 31 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- &Partners held 20,111 shares of iShares Biotechnology ETF worth $3.82M as of Q2 2026.
- &Partners bought 487 iShares Biotechnology ETF shares in Q2 2026, an estimated $83.7K.
- iShares Biotechnology ETF made up 0.02% of &Partners's portfolio in Q2 2026, its #703 holding.
- &Partners first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 31 quarters since.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.